Early Infant HIV Treatment in Botswana

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

May 4, 2015

Primary Completion Date

November 6, 2020

Study Completion Date

June 30, 2029

Conditions
HIVPediatric AIDS
Interventions
DRUG

Nevirapine

DRUG

Kaletra

DRUG

Lamivudine

DRUG

Zidovudine

Trial Locations (1)

Unknown

Botswana Harvard HIV/AIDS Institute Partnership, Gaborone

All Listed Sponsors
collaborator

Ragon Institute of MGH, MIT and Harvard

OTHER

collaborator

Brigham and Women's Hospital

OTHER

collaborator

Botswana Harvard Health Partnership

UNKNOWN

collaborator

University of California, San Diego

OTHER

lead

Harvard School of Public Health (HSPH)

OTHER

NCT02369406 - Early Infant HIV Treatment in Botswana | Biotech Hunter | Biotech Hunter